External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Roche and Genentech at

Options XII 2024

-
Coming soon
08:30 AM
Duration 24hrs Brisbane, Australia
Multi-center Clinical Performance Evaluation of a Molecular Point of Care Test for SARS-CoV-2 & Influenza A/B
Elissa M Robbins

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
12:30 AM
Duration 25mins Mezzanine Room M4, Brisbane Convention & Exhibition Centre, Brisbane, Australia
Phase III CENTERSTONE study of single-dose baloxavir marboxil▼ for the reduction of transmission of influenza in households
Ben Cowling

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
06:00 AM
Duration 4mins Brisbane, Australia
Stop the flu going viral: the benefits of antivirals for patients, households and communities
Frederick Hayden

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 10mins Brisbane, Australia
Patients: clinical management of influenza in children and adolescents in China
Mei Zeng

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 11mins Brisbane, Australia
Households: protect people by reducing transmission
Ben Cowling

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar
Duration 16mins Brisbane, Australia
Communities: impact of reduced transmission on epidemics and pandemics
Colin Russell

Sign up or login to unlock the full suite of MEDICALLY features

Add to calendar